ANCA ASSOCIATED VASCULITIS (AAV)

Clinical trials for ANCA ASSOCIATED VASCULITIS (AAV) explained in plain language.

Never miss a new study

Get alerted when new ANCA ASSOCIATED VASCULITIS (AAV) trials appear

Sign up with your email to follow new studies for ANCA ASSOCIATED VASCULITIS (AAV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 9 Not yet recruiting 3 Not yet finished but already full! 1 Terminated 1

One-Shot cell therapy tested for Hard-to-Treat lupus and related diseases

Disease control Terminated

This was an early, exploratory study to test the safety of a single infusion of a patient's own modified immune cells (CAR T-cells) for people with severe autoimmune diseases that did not respond to standard treatments. The trial aimed to see if this one-time therapy could help c…

Matched conditions: ANCA ASSOCIATED VASCULITIS (AAV)

Phase: EARLY_PHASE1 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control

Last updated Mar 16, 2026 15:25 UTC

ANCA ASSOCIATED VASCULITIS (AAV)

Get alerted when new ANCA ASSOCIATED VASCULITIS (AAV) trials appear

One-Shot cell therapy tested for Hard-to-Treat lupus and related diseases